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We performed 2 types of experiments to reveal aspects 
of Langerhans cell function. In the 1st type, tail skins 
(mice) and cheek pouches (hamster s) were grafted het-
erotopically to the thoracic wall of normal recipients and 
were subsequently painted with immunizing doses of a 
chemical contactant, dinitrofluorobenzene. In the 2nd 
type, corneal tissue and skin irradiated with ultraviolet 
light were grafted to recipients immunogenetically dis-
parate for class I (murine K/D) or class II (Ia) antigens 
to determine the ability of these grafts to elicit allograft 
immunity. We found that the inability of intact murine 
tail skin to support the induction of contact sensitivity 
was a property of the skin itself, not of the anatomical 
site. The inability to sensitize through cheek pouch was 
a property of the anatomical arrangement of the pouch 
in that an effective lymphatic drainage pathway did not 
exist. Although ultraviolet light apparently depleted 
body wall skin of ATPase-positive cells, it failed to rid 
skin of its capacity to express Ia antigens in a highly 
immunogenic way. Cornea grafts differing from their 
hosts across the I region alone of the major histocom-
patibility complex succeeded neither in inciting their 
own rejection nor in prejudicing the host's subsequent 
response to body wall skin allografts bearing the same 
I region antigens. These results are strong circumstan-
tial evidence that Langerhans cells are the important 
epidermal factors promoting induction of contact hyper-
sensitivity. illtraviolet light appears to be an effective 
way in which to transiently perturb Langerhans cell 
function, but is not an effective means of removing Lan-
gerhans cells from skin. The results of the cornea graft 
experiments offer hope that, when effective means of 
erasing Langerhans cells from skin have been found, 
skin will be devoid of its capacity to promote contact 
hypersensitivity and to elicit allograft immunity directed 
at Ia antigens. 
Experimental studies on epidermal Langerhans cells have 
utilized a variety of approaches. In t he studies discussed in th e 
2 other p apers we have presented here [1,2), we investigated 
Langerhans cell properties in 2 ways. Firs t, we used a morpho-
logical approach to the quantification ofLangerhans cells in the 
epidermis by taking advantage of the capacity of skin grafting, 
ultraviolet light (UVL) irradiation, and skin painted with nox-
ious agents that induce contact hypersensitivity in order to 
alter normal Langerhans cell numbers and function . These 
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studies led to the realization that under normal circumstances, 
considerable variation in Langerhans cell density and distribu-
t ion exists among cutaneous sUTfaces. As a consequen ce of th ese 
morphological observations, we constructed several hypotheses 
that led to a 2nd avenue of investigation, in which we examined 
t he functional properties of skin with natural and experimen-
tally induced alterations in Langerhans cells. We used per-
tW'bed, but anatomically intact, skin to study the capacity of 
skin to promote contact h ypersensitivity. The most interesting 
and provocative fmding was that skin deficient in normal num-
bers a nd in distribution of Lan gerh ans cells promoted th e 
development of specific immunologic tolerance to a chemical 
contactant. 
A 3rd approach to analyzing th e physiological role of Lan-
gerhans cells was to utilize in vivo grafting techniques. We used 
grafts of normal body wall skin , skin fro m regions with unusual 
Langerhans cell densities, and skin in which Langerhans cells 
were putatively depleted. The results revealed that Langerhans 
cells are essential to, but not of th emselves sufficient for, th e 
induction of contact hypersensitivity and th e induction and 
expression of allograft immunity . 
MATERIALS AND METHODS 
Animals 
Mice of the fo llowing strains were obtained from our domestically 
maintained stocks: C57BL/6, A.AL, A.TL, A.TH, BlO.A, BlO.AQR, and 
BlO.T(6R). The LSH hamsters were also obtained from our domestic 
stocks. Animals were between 2 and 4 rna of age at the time of 
experin1entation. Panels of experimental and control animals were 
matched for age and sex. 
Grafting 
Full-thickness skin grafts were prepared from body wall skin and tail 
skin as described elsewhere [3). Corneal grafts were carefully excised 
free of limbic tissue and placed, endothelium-side-down, on prepared 
graft beds [4]. Cheek pouch grafts were prepared from excised cheek 
pouches from which extraneous subdermal areolar tissue had been 
removed. Graft beds were created on the surfaces of the thoracic walls 
of recipient animals; precautions were taken to ensure that in each a 
panniculus carnosis layer was intact. Grafts were wrapped in plaster of 
Pru·is bandages, which were removed 8 days later. Grafts were inspected 
daily for evidence of. rejection; rejection was judged to have occurred 
when all evidence of epidermis was gone from the gt·aft surface. Median 
survival tin1es were calcl.\lated according to the method of Litchfield 
and Wilcoxon (5]. 
Sensitization to Dinitroflu.oroben zen.e 
The method of dinitrofluorobenzene (DNFB) sensitization has been 
described elsewhere [6]. Two applications at 24-hr intervals of 25 fLl of 
0.5% DNFB in carrier (4:1, acetone:sweet oil) were placed at appropriate 
cutaneous sites. Fow· days later, dorsal sw·faces of ears received 20 fLl 
of 0.2% DNFB in carrier. The amounts of swelling, measured 24 and 48 
hr later with a micrometer, were expressed as mean differences in 
inches (X w-•). Positive controls consisted of normal animals whose 
abdomens had been painted twice with DNFB as described above and 
whose ears had been challenged. Negative controls received their 1st 
exposure to DNFB as an 0.2% solution placed on the ear. 
Ultmviolet Lig':t Irmdiation 
Ultraviolet light was administered according to a method described 
elsewhere [7]. 
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EXPERIMENTS AND RESULTS 
Two types of experiments were performed. First, skin with 
unusual numbers or densities of Langerhans cells was grafted 
heterotopically to the body wall of experimental animals. When 
completely healed in place, sensitization to DNFB was at-
tempted through the grafted tissue. These experiments were 
designed to elucidate whether the inability of certain specialized 
cutaneous sites to promote contact hypersensitivity was a func-
tion of the skin itself or a property of the anatomical site where 
it resided. Second, skin either naturally or artificially deficient 
in Langerhans cells was assayed for its capacity to express 
transplantation alloantigens and to elicit transplantation im-
munity. 
Capacity of Heterotropic Tail Skin Grafts to Support 
Induction of Contact Hypersensitivity to DNFB in Mtce 
Since normal mouse tail skin contained far fewer Langerhans 
cells than did body wall skin [7], and since immunizing amounts 
of DNFB painted on intact tail skin did not induce contact 
sensitivity (6], it seemed important to determine whether the 
failure resulted from an inherent property of tail skin itself, or, 
alternatively, whether there was something unusual about the 
anatomical site of the tail that precluded sensitization. To 
examine this matter, we placed large (approximately 20 X 25 
mm) tail or body wall skin grafts on prepared beds of syngeneic 
C57BL/6 male mice. When the grafts had completely healed in 
place (30 days later), 25 fll of 0.5% DNFB in carrier was carefully 
applied to the surface of each graft. This procedure was :e-
peated 24 hr later. Positive controls were normal male n:1ce 
that received 2 similar paintings ofDNFB on shaved, abdommal 
wall skin. Five days later the ears of each panel of animals, plus 
those of negative controls, were challenged with 20 fll of 0.2% 
DNFB. The ear swelling response was measured 24 hr later. 
We were gratified to find that grafts of body wall ~kin re~iding 
on the thoracic wall sustained and promoted the mductwn of 
contact sensitivity to DNFB, and did so at least as well as intact 
abdominal skin (34 X 10- 4 inches versus 28 X 10-") (Table I). 
This important observation indicated that the process of graft-
ing and healing with attendant scar information did not mate-
rially interfere with the afferent limb of sensitization to the 
chemical contactant placed on the grafted skin. By contrast, 
DNFB painted on tail skin grafted heterotopically to the tho-
racic wall elicited only marginal sensitization to the contactant. 
It seemed reasonabl~ to conclude that we were observing a 
property of tail skin itself, not an artifact of the grafting pro-
cedure. Since DNFB painted on tail skin grafts resulted m a 
degree of sensitization only 36% that of the positive cont~ol 
value, we concluded that the tail skin, whether it existed at Its 
anatomically intact location on the tail or was placed hetero-
topically, was fundamentally inefficient in inducing c~n~act 
hypersensitivity. This finding formally excluded the poss1b~ty 
that our failure to sensitize mice via tail skin painted with 
DNFB was related to the anatomical location of the tail. 
Instead tail skin itself was deficient in this property. (Among 
the ma~y differences we found between tail and body wall skin, 
the anomalous densities and distributions of Langerhans cells 
were particularly striking.) We postulated that the failure of 
the tail skin to support contact hypersensitivity induction was 
related to the Langerhans-cell-associated abnormalities. 
TABLE I. Ear swelling response after dinitrofluorobenzene painting 
of heterotopic tail shins 
Ear swelling 
Immunization site N 
x 10_ .. inches % Positive control 
Body wall skin graft 4 34 121 
Tail skin graft 5 lO 36" 
Abdominal skin" 4 28 100 
Negative control 4 10 
"Significantly less than positive control, p < .01. 
"Positive control. 
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Capacity of Heterotopic Cheek Pouch Grafts to Support 
Induction of Contact Hypersensitivity to DNFB in Hamsters 
Like the murine tail, the hamster cheek pouch exhibits ab-
errations of Langer hans cell number and distribution [7]. More-
over, the cheek pouch has long been known as an immunolog-
ically privileged site in which allo- and xenogeneic normal and 
tumor tissues can be successfully grafted for extended intervals 
[8]. Histological and functional studies have revealed that the 
cheek pouch is apparently devoid of a draining lymphatic 
network; a rather thick subdermal layer of loose, areolar tissue 
containing connective tissue of unusual consistency is thought 
to function as a barrier to the movement of molecules and cells 
from the cheek pouch epidermis to the deep subdermal lym-
phatics that drain to regional lymph nodes. Our studies have 
shown that cheek pouch epidermis, unlike body wall skin, 
contains a paucity of Langerhans cells in a distribution pattern 
that is randomly uneven. 
Syrian hamsters, like mice, guinea pigs, and people, can easily 
be rendered hypersensitive to highly reactive contactants such 
as DNFB [9]. However, attempts to sensitize hamsters to 
chemical contactants through intact cheek pouch epidermis are 
fraught with real and hypothetical hazards. Although the pouch 
is easily evertable, one can not guarantee that DNFB painted 
thereon will not be swallowed by the animal once the pouch 
has been returned to its orthotopic site. Oral administration of 
contactants has been shown to be an excellent way to render 
guinea pigs and mice tolerant [10,11]. Thus, we elected to attack 
this issue by placing cheek pouch grafts heterotopically on the 
thoracic walls of syngeneic hamsters. When these grafts had 
healed in place and all evidence of acute inflammation had 
subsided, 2 applications of 0.5% DNFB spaced at 24-hr intervals 
were placed carefully on the graft surfaces. For controls, other 
hamsters that had received grafts of body wall skin on their 
thoracic cages received similar DNFB paintings on their grafts. 
At the time of application, the surface area of both types of 
graft was approximately 600 mm2. The results of ear challenges 
of these animals are presented in Table II. 
The body wall skin grafts in hamsters were as efficient as 
comparable grafts in mice at promoting the induction of contact 
hypersensitivity. The ear swelling of these animals (49 X w-·l 
inches) was virtually identical to that of the positive controls 
whose intact abdominal skin had been painted (56 X 10 --~ ). By 
contrast, the mean ear swelling of the panel of cheek-pouch-
grafted hamsters was only 32 X 10-'', a value that exceeded the 
ear swelling of the negative control animal by only 7 x 10- 4 
inches. In 3 of the 5 animals with cheek pouch grafts, the ear 
swelling was indistinguishable from that in negative controls. 
However, in the other 2 animals, there was significant, albeit 
modest, ear swelling, an indication that a certain degree of 
hypersensitivity had been elicited. The cheek pouch grafts of 
these 2 animals simultaneously displayed an unexpected pat-
tern of reactivity. Erythema developed in all DNFB-painted 
cheek pouch grafts within 24 hr of application. In the 3 instances 
in which no sensitivity emerged, the erythema faded within 72 
hr. However, in the 2 animals that ultimately became sensitized 
(as measured by ear swelling) small necrotic areas were pro-
TABLE II. Ear swelling response after dinitro(luorobenzen.e 
painting of heterotopic cheeh pouch grafts 
Immunization site N 
Ear swelling 
X lO- < inches % Positive control 
Body wall graft 5 49 78 
Cheek pouch graft 5 32 22" 
Abdominal skin" 4 56 100 
Negative control 4 (25) 0 
"Of 5 animals, 2 had moderate ear swelling. We found violent inflam-
mation in theu· cheek pouch grafts; this resulted in graft destruction 7 
days after application of dinitrofluorobenzene. Ear swelling of 32 was 
significantly less than that of the positive control, p < 0.01. 
" Positive control. 
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duced in the grafts by DNFB painting; a violent inflammatory 
reaction then developed in the cheek pouch grafts beginning 4 
days after painting. The intensity of the reaction mounted 
during the next several days and finally culminated in complete 
graft destruction between days 7 and 8. As mentioned in another 
paper presented in this volume [1], cheek pouch grafts placed 
heterotopically rather quickly accumulated increased numbers 
of Langerhans cells in the epidermis. By day 30, at the time of 
DNFB painting, the density of Langerhans cells in these grafts 
approached that of the surrounding body wall skin. We inter-
preted the results of our cheek pouch painting experiments as 
follows: so long as DNFB painting of the cheek pouch epithe-
lium failed to produce surface necrosis (and thereby preserved 
the "barrier"), contact sensitivity did not develop. However, 
when the toxicity of DNFB was sufficient to cause ulceration of 
the cheek pouch epithelium, systemic sensitization did ensue. 
The sensitivity expressed itself not only at the ear challenge 
site, where dilute DNFB was applied, but also at the original 
pouch graft site, where significant numbers of Langer hans cells 
and keratinocytes derivatized with DNFB remained. As a con-
sequence, the effector limb of the immune response attacked 
the graft site and caused its destruction, much as it would have 
attacked an alien allograft. 
We concluded from the cheek pouch experiments and the tail 
skin graft experiments that normal numbers of evenly distrib-
uted Langerhans cells were required to produce contact sensi-
tivity to DNFB. Epidermis in which Langerhans cells were 
abnormal in 1 or both of these respects was incapable of 
supporting contact sensitization. However, epidermis contain-
ing an appropriate density of Langerhans cells could not, by 
itself, promote sensitization. The tissue also had to possess an 
intact lymphatic pathway for the regional dissemination of the 
immunogenic signal. When that pathway was blocked, as it 
apperu·ed to be in the functionally intact hamster cheek pouch, 
induction of sensitivity failed to take place. 
Alloantigenicity of Shin Grafts after Ultraviolet Light 
Irradiation 
More than a decade ago, Steinmuller produced the fu·st 
convincing evidence that nonparenchymal cells, i.e., cells of 
extracutaneous origin, contributed to the antigenicity of full-
thickness skin allografts [12]. It has been assumed that these 
cells are derived from the peripheral blood, which delivers them 
to the skin. Therefore, the term "passenger cells" (or "passenger 
leukocytes") has been applied to them [13]. Their precise 
morphological identification has never been established: Per-
haps more than 1 type of cell participates. It is not umeasonable 
to suggest that Langerhans cells, derived from mesenchyme, 
function in allografts as "passenger cells." We elected to ex-
amine this possibility by taking advantage of the fact that skin 
irradiated with UVL loses the vast majority of its ATPase-
positive (Langerhans) cells [7] and fails to support the induction 
of contact hypersensitivity [6]. We hypothesized that UVL-
treated skin might be relatively deficient not only in Langerhans 
cells but also in the unique cell sw·face (Ia) antigens they 
express. 
In that regard, class I histocompatibility antigens (mw·ine K/ 
D) are expressed on virtually all cells of the body; class II 
antigens (murine Ia) ru·e restricted in expression primarily to 
lymphoreticular cells [14,15]. In the epidermis, keratinocytes 
and-Langerhans cells both express class I determinants, but 
only Langerhans cells express class II antigens [16,17]. We 
chose 6 inbred mouse strains (Table III) because they differed 
n·om each other only at the K region of H-2 (class I) or at the 
I region (class II). Skin graft donors received 4 daily exposures 
to UVL according to the schedule reported previously. After 
the terminal treatment, skin grafts were prepared n·om the 
irradiated areas and were placed on recipient mice. These grafts 
were monitored until rejection had taken place. Median survival 
times were calculated and compared with 1st-set controls whose 
grafts had received incandescent light treatment. Recipient 
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TABLE III. H -2 genotypes of mouse strains employed 
H-2 regions 
Strain 
K I s D 
A.AL k k k d 
A.TL s k k d 
A.TH s s s d 
B10.A k k/d d d 
B10.AQR q k/ d d d 
B10.T(6R) q q q d 
TABLE IV. Effects of ultraviol~t light irradiation on alloantigen.icity 
of sllin allografts 
H-2 dispar- Graft survivar' Host Donor ity 
I SL set 2nd set 
l. A.TL A.AL-UVU K 12.5 8.3 
2. A.TL A.AL K 11.5 9.0 
3. A.TL A.TH-UVL I 11.6 8.5 
4. A.TL A.TH I 12.4 8.5 
5. B10.A B10.AQR-UVL K 11.4 8.8 
6. BlO.A B10.AQR K 11.5 8.1 
7. B10.AQR Bl0.T(6R)-UVL I 12.5 10.5 
8. BlO.AQR B10.T(6R) I 11.0 10.0 
"Median survival time in days. 
"Abbreviation: UVL, ultraviolet light. 
mice then received grafts of normal skin syngeneic with the 
donors of the UVL-treated skin. These 2nd-set grafts were also 
monitored until rejection and were compared with 2nd-set 
grafts on control animals. The results of these experiments are 
displayed on Table IV. 
We did not expect class I antigens, expressed on keratino-
cytes, to be affected by UVL treatment, and they were not. The 
UVL-treated and normal grafts from A.AL and BlO.AQR do-
nors were rejected with eq ual vigor by A.TL and BlO.A mice, 
respectively. If UVL treatment effectively removed Langer hans 
cells from the epidermis, UVL-treated grafts from A.TH and 
B10.T(6R) should have enjoyed prolonged survival on A.TL 
and BlO.AQR recipient mice, respectively. They did not! More-
over, when these animals were rechallenged with normal A.TH 
and 6R skin grafts, respectively, they rejected the grafts in an 
accelerated manner, an indication that the 1st graft had im-
munized to class II (Ia) antigens of the donor. 
It might be argued that the donor grafts in these experiments 
contained, among the passenger cell component, immunocom-
petent cells of the donor that were potentially able to react to 
host antigens and thus initiate within the graft bed itself a mild 
graft-versus-host reaction. To rule out this unlikely possibility, 
we carried out similru· experiments with appropriate F, hybrid 
donors whose skin was irradiated with UVL. The results (not 
shown) were identical to those reported above. Even F, grafts 
treated with UVL sensi tized their recipients to donor class II 
antigens. 
There are 2 possible explanations for these results, either or 
both of which may be valid: (a) Langerhans cells were not the 
major contributors to the Class II alloantigenicity of the skin 
grafts and (b) UVL irradiation did not rid the epidermis of 
these cells (on the basis of grafting criteria). 
Alloantigenicity of Cornea Grafts in Mice 
Our efforts to deplete body wall epidermis absolutely of 
Langerhans cells were not successful. Therefore, we turned to 
grafts prepru·ed from mouse cornea because of unequivocal 
evidence that this highly specialized epidermal tissue is devoid 
of Langer hans cells and other dendritic cells [ 4,18,19]. Corneas 
from donor mice were removed and their limbic attachments 
were carefully excised to ensure that tissue potentially laden 
with Langerhans cells was not included. Three such grafts, 
epidermal-side-!Jp, were placed heterotopically on beds pre-
pared on the thoracic walls of recipient mice. In preliminary 
experiments, syngeneic corneal grafts sw-vived sw-prisingly well: 
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TABLE V. First-set allografts: Cornea versus body wall shin 
Host Donor Antigen Type MST" 
1. BlO.AQR B10.A K" body wall 16.0 
2. B10.AQR B10.A K" cornea 13.2 
3. A.TH A.TL r body wall 16.2 
4. A.TH A.TL r cornea >45 
5. A.TH A.AL K"r body wall 14.8 
• Abbreviation: MST, median survival time in days. 
TABLE VI. Allograft immunity induced by cornea versus body wall 
shin 
Sensitizing graft 2nd-set graft 
Host 
Antigen Type Antigen MST" 
1. B10.AQR K" body wall K" 9.0 
2. B10.AQR K" cornea K" 9.0 
3. A.TH r body wall K"r 9.5 
4. A.TH r cornea K"r 14.8 
5. A.TH K"r body wall K"r 9.0 
6. A.TH none K"r 15.0 
" Abbreviation: MST, median survival time in days. 
so long as a protective dressing of Vaseline-impregnated gauze 
was applied, they retained their transparency; when exposed to 
room air, the grafts became translucent but kept therr dome-
shaped configuration owing to the unique structure of the 
corneal stroma. Grafts such as these have been observed to 
remain in good condition for more than 60 days. 
In experiments analogous to those just described for UVL-
treated skin grafts, we tested whether corneal grafts between 
donor-recipient pairs disparate only for class II antigens would 
initiate specific allograft sensitization. The results of these 
experiments are displayed in Table V (lst se~) and T_able VI 
(2nd set) . Corneal grafts expressed class I antigens qmte well; 
they instigated their own specific rejection (line 2, Table V). By 
contrast, corneal grafts disparate from their recipients only for 
class II antigens were not rejected (line 4, Table V). When these 
recipients were rechallenged with body wall skin bearing class 
II antigens syngeneic with the corneal graft donors, the grafts 
were rejected in typical lst-set fashion (line 4, Ta?le VI)~ an 
indication that the original corneal graft had not rrnmuruzed 
against these antigens. Importantly, corneal grafts disparate 
from their recipients for class I antigens not only were reJected, 
but also caused the development of 2nd-set reactivity when the 
animals were subsequently challenged with body wall skin of 
the same phenotype. 
We concluded that the corneal grafts did not express Ia 
antigens in our in vivo functional assay. Moreover, since the 
corneal grafts were absolutely deficient in Langerhans cells but 
did have a resident population of other mesenchymal cells 
(including lymphocytes), we inferred that Langer han~ cells we~e 
probably the major, if not the only, source of cells m th~ skin 
capable of expressing class II antigens in an immunogenetically 
important manner. 
DISCUSSION 
A vast body of evidence has accumulated over the past few 
years that Langerhans cells play a dominant role in the process 
by which antigens presented_ through cutaneous s~aces are 
perceived by the immu~J.Ologic app~atus. W orke~s m several 
laboratories have contnbuted to this body of ev1dence. The 
watershed discovery was that Langerhans cells were not related 
to melanocytes [20], but represented a unique epidermal cell 
type, probably derived from mesenchym~ [21]; then ~angerhans 
cells began to become associated expenmentally With c?ntact 
hypersensitivity reactions [22,23]. The surface determmants 
and properties of these cells were fouJ?d to clos~ly res~mbl_e 
those ofmacrophages [16,24,25]; strong tn mtro evidence Impli-
cated Langerhans cells in the important process of antigen 
presentation to immunocompetent lymphocytes [25]. In our 
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own laboratory, we have studied Langerhans cells in vivo by 
using cutaneous surfaces containing aberrant densities and dis-
tributions of Langerhans cells and by manipulating Langer hans 
cells artificially with UVL and chemical irritants. We have been 
rewarded with an illuminating series of findings. First, cuta-
neous sites with unique immunologic properties have fewer 
Langerhans cells than normal skin sites, and the distribution of 
cells is aberrant. Second, Langerhans cells and their influence 
can be effectively depleted from skin by exposure to UVL. 
Third, anatomically intact skin deficient in Langerhans cells 
does not promote the induction of contact hypersensitivity. 
Fourth, heterotopic grafts of skin deficient in Langerhans cells 
do not permit contact sensitization, an indication that the 
failure is due to an inherent property of that skin. Fifth, 
epidermis absolutely devoid ofLangerhans cells cannot express, 
in an immunogenicaily active form, class II antigens of the 
major histocompatibility complex, even though other lympho-
reticular cells may be present in the graft. Sixth, and most 
importantly, cutaneous surfaces depleted of Langerhans cells 
promote the development of specific immunologic tolerance to 
antigens painted thereon. 
We have not yet fulfilled Robert Koch's famous postulates as 
they pertain to Langerhans cell function, that is, we have not 
reconstituted a putative Langerhans cell-dependent function by 
the addition of exogenous Langerhans cells. The closest we 
have come has been in the corneal allograft experiments, in 
which we have become absolutely sure that the grafts being 
used are devoid of Langer hans cells. Until a successful method 
for preparing cell suspensions selectively purified for Langer-
hans cells has been devised, the amassed evidence must remain 
circumstantial. 
We are also cautioned by the observations made with cheek-
pouch-grafted hamsters. In our enthusiasm to assign a pivotal 
role to Langerhans cells in the induction of immunity to chem-
ical contactants, we transiently overlooked the much older 
observation of Barker and Billingham that cheek pouches 
lacked a lymphatic drainage pathway [8]. The results of our 
experiments remind us that fundamentally we know nothing 
about the transduction of"antigen" into an immunogenic signal. 
Do Langerhans cells, once derivatized with hapten, drop down 
through the dermal-epidermal junction and travel through the 
afferent lymphatics to present the antigen at the draining node? 
Or is the signal somehow imparted to recirculating T lympho-
cytes passing through the epidermis, and must these cells then 
traffic back to the draining node? Could it be that the draining 
lymphatic is not important because of the strategic location of 
the regional lymph node? Perhaps immunologic recognition by 
T lymphocytes occurs within the epidermis itself, upon a sub-
strate prepared by antigen-derivatized Langerhans cells, and 
the activated T cells must gain access to the systemic circulation 
through the lymphatic route. 
With this last possibility, our attention retmns to the hy-
pothesis that an integrated system of skin-associated lymphoid 
'tissue (SALT) exists [13). The results of our experiments could 
be interpreted to mean that in the constellation of tissues and 
cells that constitute SALT, Langerhans cells are the anatomical 
outposts within the integument, and that recirculating lympho-
cytes become specialized by developing "affmities" for Langer-
hans cells, thus accounting for their apparent attraction to skin. 
As sentinels within the epidermis, Langerhans cells provide a 
continuous network of dendritic processes for the efficient cap-
tme and processing of cutaneously presented antigen. Effective 
presentation of antigens to wandering skin-specific lymphocytes 
becomes their major physiological role. Where the Langerhans 
cell network is attenuated or absent, e.g., the cornea, one might 
expect the cutaneous surface to be especially vulnerable im-
munologically and to permit antigens presented at that site to 
be perceived as tolerogens rather than as immunogens. We can 
only speculate upon the possibility that the recurrent, devas-
tating keratitis that follows corneal infection with herpes sim-
July 1980 
plex virus might be an example of this phenomenon. 
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